Open-label study of Denosumab in Subjects with Giant Cell Tumor

• Research type

  Research Study

• Full title

  An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone

• IRAS ID

  5481

• Contact name

  Michael Parry

• Contact email

  michael.parry3@nhs.net

• Sponsor organisation

  Mount Vernon Hospital

• Eudract number

  2008-001606-16

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  NCT00680992

• Research summary

  N/A

• REC name

  Yorkshire & The Humber - Leeds West Research Ethics Committee

• REC reference

  09/H1307/54

• Date of REC Opinion

  14 Sep 2009

• REC opinion

  Further Information Favourable Opinion